131 filings
Page 3 of 7
8-K
w18u6
12 May 21
Salarius Pharmaceuticals Reports First Quarter Financial Results with Business Highlights
4:03pm
8-K
j46jya 5p97t3mxlk9n
8 Mar 21
Salarius Announces Pricing of $20 Million Underwritten Public Offering of Common Stock
4:30pm
8-K
llcrz9veu7 bo41
3 Mar 21
Salarius Announces Proposed Public Offering of Common Stock
4:23pm
8-K
vf6zb idcdgqos
17 Feb 21
Other Events
4:00pm
8-K
ezh79nbk
5 Feb 21
Entry into a Material Definitive Agreement
4:41pm
8-K
35n 38897lg5zqya
21 Jan 21
Other Events
8:00am
8-K/A
xn5g3ebbhc wb
11 Dec 20
Financial Statements and Exhibits
5:01pm
8-K
fy0mog y5q
11 Dec 20
Entry into a Material Definitive Agreement
8:28am
8-K
u10a jp4jvll7k0
12 Nov 20
Salarius Pharmaceuticals Reports Business Highlights and Third Quarter 2020 Financial Results
8:01am
8-K
zz9n1k9
6 Oct 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:59pm
8-K
dwx4x9i1b2ijl2uh5l5
12 Aug 20
Salarius Pharmaceuticals Reports Business Highlights and Second Quarter 2020 Financial Results
4:10pm
8-K
tqukhd6i9vn4
3 Aug 20
Salarius Announces Pricing of $5.3 Million Underwritten Public Offering
4:29pm
8-K
s2azp9xkrawtbohzll
29 Jul 20
Salarius Announces Proposed Public Offering of Common Stock
4:34pm
8-K
21ujus903 hcu
19 Jun 20
Submission of Matters to a Vote of Security Holders
5:26pm
8-K
c8qsrqgw1w1v2
18 Jun 20
Other Events
4:34pm
8-K
ppdk0
14 May 20
Salarius Pharmaceuticals Reports First Quarter 2020 Financial Results
4:09pm
8-K
74ftxpsoc42g
29 Apr 20
Departure of Directors or Certain Officers
4:31pm
8-K
p2p9hl
10 Apr 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:14pm
8-K
kzvwp
27 Mar 20
Salarius Pharmaceuticals Reports Fourth Quarter and Full-Year 2019 Financial Results
4:35pm
8-K
b4ao4rten0zsnd9 k860
11 Mar 20
Other Events
4:28pm